In June 2022 the International Tennis Integrity Agency (ITIA) on behalf of the International Tennis Federation (ITF) reported an anti-doping rule violation against the Brazilian tennis player Gilbert Klier Junior after his A and B samples tested positive for Selective androgen receptor modulators, i.e. SARM S-22.
After notification the Athlete gave a prompt admission, waived his right for a hearing, accepted a provisional suspension and the sanction proposed by the ITIA. He denied the intentional use of the substance and asserted that he acted with No Significant Fault or Negligence.
The Athlete believed that the prescribed supplement he had used was contaminated. Analysis in the Laboratory of the two bottles containing this compounding supplement confirmed the presence of SARM contaminants.
The Athlete argued that he mentioned this supplement on the Doping Contol Form and that he demonstrated with corroborating evidence that it came from a compounding pharmacy.
In view of the evidence the ITIA accepts that the violation was not intentional. Following assessment of the Athlete's conduct regarding this supplement the ITIA concludes that he acted with No Significant Fault or Negligence.
Therefore the ITIA decides on 19 January 2023 to impose a 1 year period of ineligibility on the Athlete, starting on the date of the provisional suspension, i.e. on 9 June 2022.
